I'm LongbridgeAI, I can summarize articles.Hong Kong’s mid-cap stocks are increasingly turning to capital return initiatives amid subdued market conditions. Fenbi Group (2465.HK) executed aggressive share buybacks in June, spending nearly HKD 40 million on June 13 alone—its largest single-day repurchase this year. The company followed up with additional purchases on June 14 and 17, totaling over HKD 50 million in the month. Separately, Ferretti Group (9638.HK) announced a final dividend of EUR 0.097 per share, payable June 26, reflecting steady capital distribution from the luxury yacht maker.
Other notable players like China National Materials (0626.HK) and CHC Healthcare (2142.HK) have maintained capital discipline without recent repurchase programs. CR Beer (0291.HK), Shanghai Fudan Microelectronics (1385.HK), and Zhaojin Mining (1825.HK) have similarly focused on operational execution rather than shareholder returns this quarter. Smaller listings including Tianchen International Medical (2469.HK), Biotech newcomer (89888.HK), and industrial supplier (8280.HK) remain quiet on capital allocation strategies.
The trend highlights a selective approach among mid-tier Hong Kong-listed firms, where capital deployment priorities increasingly align with shareholder value preservation rather than growth reinvestment.
